Statins and hypertension
Pro Research Analysisby 
Searched over 200M research papers
Statins and Blood Pressure Reduction in Hypertensive Patients
Research consistently shows that statins, widely used for lowering cholesterol, also have a modest but significant effect on reducing blood pressure in patients with hypertension. Multiple meta-analyses and systematic reviews have found that statin therapy leads to small reductions in both systolic and diastolic blood pressure, independent of their cholesterol-lowering effects. The average reduction in systolic blood pressure is around 1.4–1.6 mmHg, and in diastolic blood pressure about 0.8–1.0 mmHg, regardless of the type or dose of statin used Khan2024Alghamdi2020Liu2023. These effects are observed even when patients are already on antihypertensive medications, although the impact is somewhat less pronounced in those cases .
Mechanisms: Statins’ Pleiotropic Effects and Blood Pressure Regulation
The blood pressure-lowering effects of statins are thought to be due to their "pleiotropic" actions, which go beyond cholesterol reduction. Statins improve endothelial function, reduce oxidative stress and inflammation, and may interact with the renin-angiotensin system, all of which contribute to better blood pressure regulation Pelat12004Khan2024. These mechanisms may also help reduce target organ damage and improve heart rate variability in patients at high cardiovascular risk .
Statins and Blood Pressure Control in Real-World Populations
Observational studies show that hypertensive patients on statins tend to have better blood pressure control compared to those who are eligible for statins but not taking them. However, this difference is largely explained by the fact that statin users are more likely to be aware of their hypertension and to be on antihypertensive medications, rather than a direct effect of statins alone . Even so, studies using 24-hour ambulatory blood pressure monitoring confirm that statin therapy is associated with lower blood pressure readings throughout the day and night, independent of the intensity of antihypertensive treatment .
Statins in Combination Therapy for Cardiovascular Risk Reduction
Because hypertension and high cholesterol often occur together and both increase the risk of cardiovascular disease, treating both conditions simultaneously is important for reducing overall risk. Evidence from large clinical trials supports the use of statins in addition to antihypertensive therapy, especially in patients with stage 2 hypertension or those at intermediate to high risk for cardiovascular events Cífková2009McNavish2022. The combination of statins and antihypertensive drugs provides greater protection against heart attacks and strokes than treating either condition alone Cífková2009McNavish2022.
Statins and Portal or Pulmonary Hypertension
While statins have shown some promise in reducing the risk of pulmonary hypertension, particularly in patients with chronic obstructive pulmonary disease, the evidence for their effectiveness in lowering portal hypertension (a complication of liver disease) is not significant Jamialahmadi2023Wu2020. The protective effect against pulmonary hypertension appears to be dose- and duration-dependent .
Conclusion
Statins offer a modest but consistent reduction in blood pressure in patients with hypertension, in addition to their well-established cholesterol-lowering and cardiovascular protective effects. These benefits are likely due to multiple mechanisms beyond lipid lowering. While the direct impact on blood pressure is small, the combined use of statins and antihypertensive medications is recommended for patients at increased cardiovascular risk, as it leads to better overall outcomes.
Sources and full results
Most relevant research papers on this topic